Russell John Race
Keine laufenden Positionen mehr
Profil
Russell John Race formerly worked at TClarke Plc, as Non-Executive Chairman, Chatham Maritime Trust, as Chairman, NeuTec Pharma Ltd., as Non-Executive Director, and Hoare Govett Ltd., as Principal in 2004.
Ehemalige bekannte Positionen von Russell John Race
| Unternehmen | Position | Ende |
|---|---|---|
| Hoare Govett Ltd. | Corporate Officer/Principal | 15.05.2004 |
Chatham Maritime Trust
 Chatham Maritime Trust Investment Trusts/Mutual FundsMiscellaneous Chatham Maritime Trust undertakes the maintenance and guardianship of the Estate for the benefit of local stakeholders, i.e. everyone who lives on or uses the Estate. The Trust deals with the day-to-day management of the estate from an office on the estate with a small professional team. It has four member organizations: Medway Council, HCA and the Estate's two occupier associations: St Mary's Island Residents Association Ltd (residential) and South Maritime Residents Ltd (non-residential). The company was founded on April 1, 1997 and is headquartered in Chatham Maritime, the United Kingdom. | Vorsitzender | - |
| TCLARKE PLC | Vorsitzender | - |
NeuTec Pharma Ltd.
 NeuTec Pharma Ltd. BiotechnologyHealth Technology NeuTec Pharma Ltd. develops biopharmaceutical products. It specializes in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections. The firm's products include Mycograb and Aurograb. The company was founded in 1997 and is headquartered in Camberley, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TCLARKE PLC | Industrial Services |
| Private Unternehmen | 3 |
|---|---|
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology NeuTec Pharma Ltd. develops biopharmaceutical products. It specializes in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections. The firm's products include Mycograb and Aurograb. The company was founded in 1997 and is headquartered in Camberley, the United Kingdom. | Health Technology |
| Hoare Govett Ltd. | Finance |
Chatham Maritime Trust
Chatham Maritime Trust Investment Trusts/Mutual FundsMiscellaneous Chatham Maritime Trust undertakes the maintenance and guardianship of the Estate for the benefit of local stakeholders, i.e. everyone who lives on or uses the Estate. The Trust deals with the day-to-day management of the estate from an office on the estate with a small professional team. It has four member organizations: Medway Council, HCA and the Estate's two occupier associations: St Mary's Island Residents Association Ltd (residential) and South Maritime Residents Ltd (non-residential). The company was founded on April 1, 1997 and is headquartered in Chatham Maritime, the United Kingdom. | Miscellaneous |
